Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1 http://leerink.metameetings.com/confbook/immunooncology15/agenda.php Sarepta Therapeutics Inc to Discuss Corporate Update and Report on Recent Data from Phase IIb Study of Eteplirsen for Duchenne Muscular Dystrophy Conference Call Thursday, October 1, 2015 7:00 a.m. ET http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-newsArticle&ID=2090453 http://edge.media-server.com/m/p/r3ugy959